TCCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study January 02, 2015Vol.37 No.12
FreeTCCL Archive Cyramza Combination Approved in Advanced Gastric Cancer December 01, 2014Vol.37 No.11
FreeTCCL Archive Galeterone Shows Potential in CRPC AR Variants, Study Says December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer December 01, 2014Vol.37 No.11
FreeTCCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III December 01, 2014Vol.37 No.11
Drugs & TargetsFreeTCCL Archive FDA Approves Velcade Injection In Mantle Cell Lymphoma October 30, 2014Vol.37 No.10
